Orange Book product · Brand (NDA)
YOSPRALA
ASPIRIN; OMEPRAZOLE
At a glance
Sep 14, 2016
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 14, 2016
9 yr 11 mo ago
Today
Patent 9987231 expires
Listed method-of-use patent (U-2324) expiration.
Jan 02, 2033
in 6 yr 8 mo
Patent 9539214 expires
Listed method-of-use patent (U-1902) expiration.
Mar 13, 2033
in 6 yr 10 mo
Pharmaceutical detail
Active ingredient
ASPIRIN; OMEPRAZOLE
Strength
81MG;40MG
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 205103
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9987231 | Jan 02, 2033 | in 6 yr 8 mo | U-2324 |
| 9539214 | Mar 13, 2033 | in 6 yr 10 mo | U-1902 |

